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Background: Restoration of the mechanical and endocrine functions of the left atrium remains controversial after
electrical cardioversion treatment for persistent atrial fibrillation. The objective of the prospective study was to
describe the recovery of the endocrine and mechanical functions of the left atrium.
Methods: Evaluation of left atrium recovery after electrical cardioversion by the new speckle-tracking echocardiography
technique and proANP measurement.
Results: Twenty patients suffering from persistent atrial fibrillation with no alteration of left ventricular ejection fraction
were prospectively evaluated at baseline and then one month later by echocardiography, measuring left atrial volume
and left atrial deformation (MPALS), as well as the proANP and BNP concentrations. One month after cardioversion 10
patients remained in sinus rhythm and 10 showed recurrent atrial fibrillation. No significant differences between the
two groups in terms of clinical, echocardiographic and endocrine parameters were observed at baseline evaluation. We
observed a significant reduction of left atrial volume only in the sinus group, whereas restoration of the left atrial
deformation was only partial (18%) in that group. By contrast, we registered no significant changes in ANP
concentration at one month in either the sinus or the atrial fibrillation groups.
Conclusion: These results suggest that restoration of left atrium mechanical function is only partial one month after
treatment of persistent atrial fibrillation by electrical cardioversion, whereas a significant reduction of left atrial volume
was noted, explaining the remaining high level of ANP in the sinus group.
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Atrial natriuretic peptideBackground
Atrial fibrillation (AF) is the most frequently encountered
arrhythmia, affecting 2% of the population [1]. Its
frequency is on the increase, in parallel with the aging
of the population, making the management of AF with
antithrombotic drugs or antiarrhythmic therapy part of
daily medical practice. AF is associated with increased
rates of mortality and morbidity due to heart failure,
stroke and other thromboembolic events as well as a* Correspondence: d.babuty@chu-tours.fr
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distribution, and reproduction in any mediumreduced capacity for exercise and reduced quality of life
[2]. AF also leads to left ventricular dysfunction [2] and
a loss of mechanical function of the left atrium [3,4].
Whether paroxysmal, persistent or permanent, AF also
stimulates the secretion of a member of the natriuretic
peptide family – atrial natriuretic peptide (ANP) [3-5].
The natriuretic peptide family includes, in addition to
ANP, two other members: brain natriuretic peptide (BNP)
and C-type natriuretic peptide (CNP). ANP and BNP are
mainly produced by atrial and ventricular cardiomyocytes,
respectively. Atrial cardiomyocytes store prohormones or
propeptides, such as proANP, in secretory granules. TheCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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and BNP is considered to be the distension of atrial and
ventricular cardiomyocytes [5-8]. The mechanical and
endocrinal effects linked to the restoration of the sinus
rhythm (SR) by cardioversion or radiofrequency ablation
remain controversial. These discrepancies can probably be
explained by the techniques used to evaluate the mechan-
ical function of the LA [4,9-13]. Most of the studies cited
above have merely provided a rough estimation of LA
mechanical function by measuring the size and volume of
the LA. However, over the last few years, more advanced
techniques to evaluate the mechanical function of the
LA have been developed, for example by analyzing the
myocardial deformation (or strain) of the atrial wall by
tissue Doppler imaging (TDI), and more recently, by an
angle-independent technique: speckle-tracking echocar-
diography [14].
We hypothetized that left atrium mechanical function
(distensibility) was incomplete one month after the
restoration of sinus rhythm, explaining a prolonged
high level of ANP. We carried out a prospective study
to evaluate the LA mechanical function by the new
angle-independent and reproducible speckle-tracking
echocardiography technique, and to gauge the endocrine
function by measuring the levels of proANP and BNP at
baseline and one month after cardioversion.
Methods
Study design
Twenty-nine patients suffering from symptomatic non-
valvular persistent AF who were admitted for direct
current cardioversion were prospectively recruited. All
patients referred to our center for electrical cardioversion
received an adequate anticoagulant (VK antagonist with
an INR between 2 and 3 during at least one month).
Persistent AF was defined as AF lasting for at least
7 days but less than one year, and requiring direct current
cardioversion [2]. Exclusion criteria for the study were
a left ventricular ejection fraction (LVEF) below 45%,
contraindication to electrical cardioversion (intracar-
diac thrombus, international normalized ratio, INR <2,
contraindication to anesthesia), refusal of consent, and
age <18 years. Only symptomatic patients were included
in the study in order to evaluate the recurrence of atrial
fibrillation after electrical cardioversion. The study protocol
was approved by the local ethics committee (CCP Tours
Région Centre Ouest 1) for human research in Tours. All
patients signed informed consent forms.
Patients were evaluated at baseline (one day before
cardioversion) and one month later, as follows: Physical
examination and standard 12-lead electrocardiogram (ECG);
standard transthoracic echocardiography with a Vivid I
digital ultrasound system (GE Medical Systems Ultrasound)
and digital cineloop format for off-line analysis using adedicated software package (EchoPac PC, version 110.1.2;
GE Healthcare); clinically required blood samples were
collected, in addition to a sample for the evaluation of
natriuretic peptides (BNP and proANP). LA function
was reevaluated one month after cardioversion because
that is generally the estimated time necessary for recovery
from atrial stunning or left atrial dysfunction [2]. Recur-
rences of atrial fibrillation after electrical cardioversion
were diagnosed on the basis of symptoms, resting ECG
and 24-hour ambulatory ECG performed by the generalist
practitioner or the cardiologist.
Direct current cardioversion was performed under
general anesthesia, with one to three biphasic shocks of in-
creasing energy, from 100 to 200 J. Patients were followed
up one month later with a physical examination, ECG,
echocardiography and blood samples for ANP, BNP
measurement.
Echocardiographic measurements
All patients were examined in the left lateral decubitus
position by M-mode, two-dimensional (2D), Doppler and
TDI echocardiography, using a 3.5-MHz transducer (GE
Medical Systems). Standard M-mode and 2D images were
obtained from 3 consecutive breath-hold cardiac cycles
and were stored in cineloop format. Apical four- and two-
chamber-view images were obtained using conventional
two-dimensional gray scale echocardiography, during breath
hold with a stable ECG recording. Particular attention was
given to obtaining an adequate gray scale image, allowing
reliable delineation of myocardial tissue and extracardiac
structures. LA volume was calculated according to the
formula 8/3π[(LA area in apical 4-chamber view * LA
area in apical 2-chamber view)/LA length. LA volume
was indexed to body surface area. The anteroposterior
diameter of the LA was also measured from the parasternal
long-axis view [15]. The left ventricular (LV) end-diastolic
diameter (LVEDD) was obtained from M-mode images
of the parasternal long-axis view. LV end-diastolic and
end-systolic volumes were measured from apical 2- and
4-chamber views, and LVEF was calculated using Simpson’s
rule [15]. The LV volumes and LVEDD were also indexed
to the body surface area. Speckle-tracking echocardiog-
raphy is a recent non-Doppler method to evaluate strain
from standard two-dimensional grayscale cineloops [16]. By
tracing the endocardial contour in both 4- and 2-chamber
views of an end-systolic frame using a point-and-click
approach, the software automatically tracks the atrial wall
in subsequent frames. Tracking accuracy can be verified
and corrected in real time by adjusting the region of inter-
est (Figure 1). We used the highest frame rate available
(60–80 frames per second).
Off-line analysis was then performed as follows. We
measured the deformation of six segments located along
the septum, the roof and the lateral wall of the LA cavity
Figure 1 Left atrial speckle-tracking echocardiography. Top. Evaluation of atrial deformation by the speckle-tracking technique. The endocardial
contour of the LA is traced in a 4-chamber view. The thickness of the region of interest is then defined. The software automatically tracks atrial wall
movements, allowing fine adjustments and verification in real time. Bottom. Strain curves for the same patient as in top figure, examined during AF
(left) and after 1 month of SR (right). Each curve represents one of the six LA wall segments; the dotted line indicates the mean strain.
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process with a 2-chamber view. A curve representing the
average of the strain curves of the six segments was auto-
matically plotted (Figure 1), where the maximum value or
“peak strain” indicated the maximum global deformation of
the LA. This value is positive, as it represents the lengthen-
ing of the LA wall during LV systole due to the filling of the
atrial cavity with blood from the pulmonary veins while the
mitral valve is closed. These measurements were repeated
for three different cardiac cycles to calculate the mean 4-
chamber peak atrial longitudinal strain (4C-PALS) and the
mean 2-chamber PALS (2C-PALS). Finally, the mean
PALS (MPALS), was calculated from both 4C-PALS and
2C-PALS [16]. Mitral regurgitation was classified as mild,
moderate or severe, according to current guidelines [17].
Two independent physicians analyzed the echocardio-
graphic measurements on ten selected subjects in order
to define the intra- and inter-observer variability.Biological assays
Because proANP half-life is longer than that of ANP, as
measured ProANP concentrations in the serum, we
used the MR-proANP kit (BRAHMS, Clichy, France).
This sandwich immunoassay uses an antibody against
the mid-region of proANP (amino acids 53–90). In 325
healthy individuals, proANP concentrations ranged from
9.6 to 313 pmol/L. The median was 45 pmol/L (95% con-
fidence interval: 43.0–49.1 pmol/L). The 99th percentile
for the control population was 197.5 pmol/L; there was no
significant difference in the range or median of proANP
values between males and females (mean: 45.3 pmol/L in
males, 45.0 pmol/L in females) [18].
BNP levels were assayed in EDTA plasma. As for
proANP, we used a sandwich immunoassay: the Triage®
BNP Test (Biosite Diagnostics, Vélizy-Villacoublay, France)
for the Access 2 system (Beckman Coulter Immunoassay
Systems, Villepinte, France). According to manufacturer
Table 1 Patients’ baseline characteristics





Age (years) 68.2 ± 10.6 66.9 ± 11.0 NS
Sex ratio n, (% female) 10 (50) 10 (50) NS
Average time between
the diagnosis of AF and
cardioversion (weeks)
11.6 ± 7.7 14.1 ± 10.2 NS
Cardiac disease n, (%) NS
Coronary disease 1(10) 1(10)
Hypertension 5 (50) 3 (33.3)





Beta blockers 6 6
Table 2 Endocrine and echocardiographic parameters at
baseline evaluation
Mean values at baseline SR group (n = 10) AF group (n = 10) p
proANP (pmol/L) 235.6 ± 62.8 226.9 ± 151.4 NS
BNP (pg/mL) 205.9 ± 99.0 197 ± 139.0 NS
LA volume/body
surface area (ml/m2)
42.3 ± 7.4 47.0 ± 15.7 NS
LVEF (%) 54.0 ± 11.1 50.5 ± 7.9 NS
4C-PALS (%) 10.9 ± 4.2 10.3 ± 4.7 NS
2C-PALS (%) 9.8 ± 5.1 11.8 ± 3.8 NS
MPALS (%) 10.4 ± 4.4 10.4 ± 4.4 NS
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the median value was 12.3 pg/mL and the 95th percentile
was 73.5 pg/mL.
Statistical analysis
Data were expressed as means ± standard deviations.
Since normality testing of the different variables showed
a non-Gaussian distribution, non-parametric statistical
tests were applied. Differences in the means of the various
parameters before and after cardioversion were assessed
by a Wilcoxon test for paired series. Differences in the
means of baseline parameters between patients with AF
and patients in SR one month after cardioversion were
assessed by a Wilcoxon test for unpaired series. Correla-
tions between LA volume or MPALS and ANP or BNP
concentrations were evaluated by the Spearman correl-
ation coefficient. A p-value < 0.05 was considered to be
significant. Statistical analyses were performed using JMP
9.0.1 software (SAS Institute, Cary, NC, USA). For the
reproducibility of the parameters, results were ana-
lyzed using Bland-Altman comparison and coefficient
of variability.
Based on our results obtained at baseline and one
month after electrical cardioversion in a limited number
of patients, we calculated the theoretical number of patients
it should be necessary to recruit to reach a significant





The study population initially consisted of 29 consecutive
patients with persistent AF who were addressed for
cardioversion. Nine patients were excluded from the
study because cardioversion failed or because the patients
were lost to one-month follow-up. The clinical character-
istics of these nine excluded patients did not differ from
other patients in terms of age (65.3 ± 10 years), sex (40%
female), associated cardiac disease, ANP level (248.9 ± 108
pmol/l), BNP level (240 ± 111 pg/ml) or echocardiographic
parameters (LA volume 45.2 ml/m2, 4C-PALS mean 11.8%;
2C-PALS mean 9%; MAPS mean 10.6%). The main charac-
teristics of the remaining 20 patients are summarized in
Table 1. None of the patients had significant mitral regurgi-
tation. One month after cardioversion, 10 patients displayed
SR (SR group) while 10 others displayed a recurrence of AF
(AF group). In the AF group all patients had at least one
symptomatic episode of AF documented on ECG and were
in AF on the day of the second evaluation. All the SR
patients were asymptomatic with normal sinus rhythm on
resting ECG and 24-hour ambulatory ECG. Clinical and
echocardiographic characteristics were not significantly dif-
ferent at baseline between the SR and AF groups (Table 1).Echocardiographic parameters
Although great care was taken to ensure the quality of
the data collected, we excluded one 4-chamber view and
three 2-chamber views because of poor quality. Inter-
observer variability coefficients of 4C-PALS, 2C-PALS and
MPALS were 9%, 13% and 8%, respectively. Intra-observer
variability coefficients of 4C-PALS, 2C-PALS and global
MPALS were 5%, 8% and 6%, respectively. No significant
difference was observed between the two independent
physicians who analyzed the echocardiographic record-
ings. Among the standard echocardiographic parameters
measured, the mean LA volume did not differ between
the SR and AF groups at baseline (Table 2). Nonetheless, a
significant diminution of LA volume was observed in the
SR group between baseline and the one-month time point
(42.3 ± 7.4 vs. 36 ± 4.4 mL/m2, p < 0.01), whereas the mean
LA volume of patients in the AF group remained un-
changed at that point (47 ± 15.7 vs. 47.5 ± 18.4 mL/m2,
p = 0.81). We noted a slight improvement in LVEF in
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vs. 60.4 ± 5.6%, p = 0.04), while no improvement in
LVEF was seen in the AF group (50.5 ± 7.9 vs. 52.9 ± 11.6%,
p = 0.77).
Not surprisingly, an analysis of atrial myocardial de-
formation revealed no difference in MPALS at baseline
between the SR and AF groups (Table 2). One month
after cardioversion, MPALS increased significantly by
76.9% in the SR group, whereas no significant change
was observed in the AF group (Figure 2). Finally, the
variation in the MPALS of all patients studied between
baseline and the one-month follow-up was well correlated
with the variation in LA volume (Spearman ρ = −0.71,
p < 0.001).
Biological parameters
High levels of proANP were observed in all patients
(Table 2), but BNP was not greatly increased in either
group. No difference between the SR and AF groups
was observed for proANP or BNP concentrations at base-
line (Table 2). ProANP concentrations one month after
cardioversion were not significantly different between the
SR (207 ± 130.4 pmol/l) and AF groups (207 ± 100.1 pmol/l).
In the SR group we observed a slight decrease in ANP
level without reaching statistical significance (Figure 3). In
the AF group the evolution of ANP level was similar that
of the other group at one month (Figure 3). Likewise,
we found no significant difference between BNP con-
centrations at baseline and those at one month in ei-
ther the SR group (205.9 ± 99 vs. 182.2 ± 180.4 pg/mL
respectively, p = 0.30) or the AF group (197 ± 139 vs.
182.5 ± 107.1 pg/mL respectively, p = 0.91).
Based on the variation of ANP levels between baseline
and one-month evaluations and the difference of mean
ANP level in the two groups observed in our pilot study,
it would be necessary to recruit 976 patients in order to
reach a statistical significant difference that could differenti-
ate the two groups.Figure 2 Variation of mean peak atrial longitudinal strain after ca
cardioversion in the SR (left) and AF(right) groups. Results are expresse
the median (50th percentile), the limits of the boxes indicate the 25th
90th percentiles.Correlation between mechanical function and
endocrine function
Before cardioversion, proANP concentrations were nega-
tively correlated with MPALS (Spearman ρ = −0.52, p =
0.027; Figure 4) but not correlated with LA volume
(Spearman ρ = 0.31, p = 0.21). In contrast, there was no
correlation between BNP concentrations and MPALS
at baseline (Spearman ρ = −0.32, p = 0.14) or between BNP
concentrations and LA volume at baseline (Spearman ρ =
0.33, p = 0.15).
One month after cardioversion, proANP concentrations
were no longer correlated with either MPALS (Spearman
ρ = −0.34, p = 0.2) or LA volume (Spearman ρ = 0.32,
p = 0.22). There was no correlation of BNP concentra-
tions with MPALS or LA volume at one month (Spearman
ρ = −0.29, p = 0.25 and Spearman ρ = 0.13, respectively,
p = 0.6).
Discussion
Our study shows that in patients with persistent AF
treated by cardioversion, LA mechanical function re-
covers faster than endocrine function, but that LA dis-
tensibility is only partial one month after sinus rhythm
has been restored. To our knowledge, this is the first
study assessing simultaneously the relationship between
LA mechanical function, as evaluated by speckle-tracking
echocardiography, and variations in proANP levels one
month after cardioversion. Previous studies evaluated
either the mechanical LA function or the endocrine
function separately [13,19], but the relationship between
the two functions could not be established and discussed.
Our population is quite similar in mean age, sex ratio
and duration of AF to those in previous studies evaluating
strain among patients with AF [19-21]. Furthermore, there
is no difference in these parameters between the SR and AF
groups at baseline. The rate of recurrence of AF at one
month despite successful cardioversion is 50% in our study,
which is comparable to that of other studies [22,23].rdioversion. MPALS (%) at baseline and one month after
d as box-and-whisker plots. The lines inside the boxes indicate
and 75th percentiles, and the whiskers indicate the 10th and
Figure 3 Variation of proANP concentrations after cardioversion. ProANP concentrations (pmol/L) at baseline and one month after cardioversion
in the SR (left) and AF (right) groups. Results are expressed as box-and-whisker plots. The lines inside the boxes indicate the median (50th percentile),
the limits of the boxes indicate the 25th and 75th percentiles, and the whiskers indicate the 10th and 90th percentiles.
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mechanical function
Over the last few years new echocardiographic techniques
have been developed and used to analyze myocardial
deformation non-invasively. Di Salvo et al. [20] have
used Tissue Doppler Imaging to study LA myocardial
deformation in patients with a history of persistent AF.
They show that the atrial lengthening (represented by
a positive peak in strain) that occurs during ventricular
ejection is significantly reduced in patients with AF.
Our study has associated standard echocardiographic
measurements of improved cardiac performance dur-
ing SR, such as an increase in LVEF and a reduction in
LA volume, with novel parameters such as an improve-
ment in MPALS. Since we observe a negative correl-
ation between the variation in LA volume and the variation
in MPALS, we may presume that LA remodeling is a
key mechanism underlying LA functional improvement.Figure 4 Correlation between MPALS and proANP concentration
at baseline. Correlation between MPALS (%) and proANP concentrations
(pmol/L) at baseline for all patients studied (SR and AF groups)
(Spearman ρ = −0.52, p = 0.027).Dell’Era et al. [19] have reported this after using the
new angle-independent technique of speckle-tracking echo-
cardiography in a larger study including 73 patients. They
reported a similar increase in MPALS (11.4 ± 5.2% in AF
and 17.2 ± 7.5% after one month in SR), using the speckle-
tracking technique. However, the recovery of mechanical
function one month after successful cardioversion appears
to be only partial, as MPALS in both our study and the
Dell’Era study [19] (around 18% in both) is considerably
lower than that of 60 healthy individuals in the report by
Cameli et al. [16] (42.2 ± 6.1%; 5–95 percentile range:
32.2–53.2%). Our results demonstrate that atrial stunning
lasts longer than one month after cardioversion. It would
therefore be of interest to assess MPALS at longer inter-
vals after cardioversion in order to determine the time to
complete recovery.
Natriuretic peptides and LA endocrine function
The particularity of our study is its focus on the link
between the mechanical and endocrine functions of the
LA. Indeed, our findings indicate that baseline proANP
concentrations are negatively correlated with baseline
MPALS, but no correlation is observed between proANP
concentrations and LA volume. After one month in SR,
the correlation between proANP levels and MPALS
disappears, because mechanical function tends to im-
prove, whereas proANP concentrations remain the same.
Wozakowska-Kaplon has shown that mean ANP and BNP
levels decrease 24 hours after electric shock and successful
cardioversion [24], and that this is followed by stabilization
of the ANP level or a gradual increase in ANP levels over
the next 30 days [24,25]. Our results confirmed this previ-
ous observation. Other authors have reported a decrease in
ANP concentrations after cardioversion [11,26], but the
interval between cardioversion and the second ANP meas-
urement is highly variable (1 to 180 days). Experimental
and clinical studies suggest that atrial volume, pressure, and
wall stretch are the main determinants of ANP secretion
[5,6,11], although the precise identity of the trigger is still
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cardioversion, we could expect a decrease in ANP con-
centrations. However, the lack of any such findings can
be explained by the results of our echocardiographic
analysis. Indeed, using the speckle-tracking technique,
we have demonstrated that one month after cardioversion,
the distensibility (MPALS) of the LA is not fully restored,
explaining the persistently high levels of ANP secretion.
These preliminary results suggest performing an evalu-
ation of the mechanical and endocrinal functions of LA
two or three months after cardioversion in selected patients.
This point could be important for patients with a low
CHA2DS2-VASC score who do not need permanent antic-
oagulation. In absence of complete restoration of the
mechanical and endocrine functions of LA one month
after electrical cardioversion a prolongation of anti-
coagulant agents could be proposed to the patients.
Several echocardiographic studies have established in
AF patients a close relationship between the risk of
thrombo embolism and the LA mechanical function [2].
Speckle-tracking echocardiography is a recent echocardio-
graphic technique that can accurately explore the con-
tractility and the distensibility of LA. Its diffusion and
development could be a useful new tool, associated with
the measurement of ANP level, for the analysis of LA.
Conclusions
Our pilot study shows that one month after cardioversion
for AF, neither the mechanical function of the LA, espe-
cially distensibility as quantified by speckle-tracking echo-
cardiography, nor its endocrine function are fully restored
in SR patients, demonstrating that atrial stunning can
exceed one month. The incomplete recovery of LA mech-
anical function contributes to high ANP concentration that
favors a prothrombotic state. The fact that complete
recovery time of endocrinal and mechanical functions
of the left atrium after electrical cardioversion is longer
than one month suggests that selected patients should
be reexamined two or three months later before changing
therapeutic agents, especially anticoagulants. A further
expanded study would be necessary to confirm these results
and their potential therapeutic applications.
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